- Home
- Equipment
- north america
- coronary sinus
Refine by
Coronary Sinus Equipment Supplied In North America
7 equipment items found
Manufactured by:Shockwave Medical Inc. based inSanta Clara, CALIFORNIA (USA)
An effective percutaneous treatment for refractory angina, a severely debilitating condition that affects millions ...
Manufactured by:Baylis Medical Company, Inc based inMontreal, QUEBEC (CANADA)
Complex Diagnostic Mapping Solutions Go Further. Know More. Enhanced diagnostic precision for coronary sinus mapping and ...
Manufactured by:Innovative Health LLC based inScottsdale, ARIZONA (USA)
This is a broad category of catheters that are used for diagnostic purposes in the EP procedure. The category includes coronary sinus and specialty catheters that are expensive and require a base level of reprocessing competency – as well as a number of fixed and steerable EP catheters. All EP reprocessors have clearances to reprocess most catheters in this ...
Manufactured by:United Biologics, Inc. based inIrvine, CALIFORNIA (USA)
This model includes external/internal jugulars down to the iliacs, and a complete structural heart including the coronary sinus. ...
by:Volta Medical based inMarseille, FRANCE
Allows for the recording of the local electrical activity. REFERENCE CYCLE LENGTH : Atrial cycle length estimated from recordings obtained with the coronary sinus catheter. MAPPING CYCLE LENGTH : Local cycle length estimated from real-time recordings obtained with the mapping ...
by:Cardiac Dimensions, Inc. based inKirkland, WASHINGTON (USA)
A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients. The goal: Treat the condition—not just the symptoms. The Carillon System is designed to work with the natural structure and function of the heart to help treat the condition of FMR as well as the related symptoms. We believe the ...
Manufactured by:Shockwave Medical Inc. based inSanta Clara, CALIFORNIA (USA)
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve regurgitation. Millions of patients worldwide with coronary artery disease who are not candidates for revascularization suffer from refractory angina ...